针对PSMA的成像和治疗的现状
Hui Wang1, GuanNan Li1, Jie Zhao1,2
1Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China.
Frontiers in oncology
|January 24, 2024
概括
前列腺特异性膜抗原 (PSMA) 向成像和治疗术为前列腺癌患者提供了新的希望. 这些先进的核医学方法正在改善诊断和治疗,特别是转移性疾病.
科学领域:
- 核医学是一种核医学.
- 在瘤学瘤学.
- 放射性药物科学 放射性药物科学
背景情况:
- 前列腺癌的发病率正在上升,对男性健康构成重大威胁.
- 像MRI这样的当前诊断方法在完全满足患者管理需求方面存在局限性.
- 转移性割抵抗性前列腺癌 (mCRPC) 往往呈现晚期,治疗选择有限,存活率差.
研究的目的:
- 审查前列腺癌中针对PSMA的成像和治疗术的当前观点.
- 突出 PSMA 放射性链体在诊断和治疗应用中的进步.
- 强调将核医学整合到多学科瘤团队中,以改善患者护理.
主要方法:
- 对前列腺癌PSMA向药物的当前文献的综述.
- 对用于成像和治疗的已批准和正在研究的PSMA放射性对象进行分析.
- 讨论临床试验结果和PSMA在患者管理中的作用.
主要成果:
- 已经开发了几种PSMA无线体对象用于前列腺癌成像和治疗术.
- 68Ga-PSMA-11和F-DCFPyL被FDA批准用于前列腺癌成像.
- 用各种同位素标记的PSMA向剂 (In, 99m, Tc, Lu, Ac) 在指导手术,检测转移,并启用内部放射治疗方面表现有前途.
结论:
- 针对PSMA的成像和治疗术正在成为前列腺癌管理的标准护理.
- 这些方法提供了更好的诊断准确性和新的治疗策略,特别是对于mCRPC.
- 将核医学医生整合到多学科团队中对于优化使用PSMA向模式至关重要.
相关概念视频
Imaging Studies II: Positron Emission Tomography and Scintigraphy
122
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
122
Positron Emission Tomography
4.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.2K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


